当前位置:首页 - 行情中心 - 复星医药(600196) - 财务分析

复星医药

(600196)

  

流通市值:491.28亿  总市值:619.73亿
流通股本:21.18亿   总股本:26.72亿

复星医药(600196)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2023年年度实现净利润28.95亿元,每股收益0.89元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2023年年度最新股东权益5661626.04万元,未分配利润2454251.12万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2023年年度最新总资产11346960.48万元,负债5685334.44万元。

利润表
报告期2023-12-312023-09-302023-06-302023-03-31
营业总收入41,399,539,588.4230,700,119,056.1221,395,192,579.8810,870,720,838.66
营业总成本41,284,076,914.3830,284,279,170.4720,632,041,911.7310,098,284,416.33
营业利润3,307,507,905.123,342,197,770.862,682,610,757.241,427,139,292.41
利润总额3,264,567,878.743,292,456,489.612,655,469,971.171,384,764,032.27
净利润2,895,063,426.582,653,809,536.672,045,225,278.441,114,254,110.16
其他综合收益31,857,159.28383,047,217.57475,605,847.37-183,486,478.67
综合收益总额2,926,920,585.863,036,856,754.242,520,831,125.81930,767,631.49
资产负债表
报告期2023-12-312023-09-302023-06-302023-03-31
流动资产合计33,792,568,948.6234,914,164,504.4436,851,027,973.835,179,941,530.99
非流动资产合计79,677,035,864.8375,853,079,792.3775,291,661,172.0672,199,433,860.8
资产总计113,469,604,813.45110,767,244,296.81112,142,689,145.86107,379,375,391.79
流动负债合计33,757,583,537.8234,506,297,652.4436,818,803,620.3432,468,080,488.92
非流动负债合计23,095,760,839.3520,278,586,889.7219,874,971,591.1819,863,580,280.01
负债合计56,853,344,377.1754,784,884,542.1656,693,775,211.5252,331,660,768.93
归属于母公司股东权益合计45,684,761,548.0545,919,376,269.1345,460,014,201.145,393,160,518.35
股东权益合计56,616,260,436.2855,982,359,754.6555,448,913,934.3455,047,714,622.86
负债和股东权益合计113,469,604,813.45110,767,244,296.81112,142,689,145.86107,379,375,391.79
现金流量表
报告期2023-12-312023-09-302023-06-302023-03-31
经营活动现金流入小计44,365,904,091.8233,435,825,453.0722,884,708,865.7711,865,511,092.17
经营活动现金流出小计40,951,687,028.2330,974,184,966.4321,074,700,731.1510,992,267,055.81
经营活动产生的现金流量净额3,414,217,063.592,461,640,486.641,810,008,134.62873,244,036.36
投资活动现金流入小计3,753,440,599.983,127,265,876.222,437,627,459.061,722,702,099.11
投资活动现金流出小计7,572,730,972.46,411,558,906.844,799,653,870.211,859,877,488.15
投资活动产生的现金流量净额-3,819,290,372.42-3,284,293,030.62-2,362,026,411.15-137,175,389.04
筹资活动现金流入小计23,590,297,864.1318,436,543,786.1713,971,277,678.257,060,114,364.32
筹资活动现金流出小计24,926,547,662.9918,833,123,390.6512,571,368,305.616,778,143,209.87
筹资活动产生的现金流量净额-1,336,249,798.86-396,579,604.481,399,909,372.64281,971,154.45
汇率变动对现金及现金等价物的影响73,645,025.18131,327,968.7741,414,806.15-67,365,428.91
现金及现金等价物净增加额-1,667,678,082.51-1,087,904,179.69889,305,902.26950,674,372.86
期末现金及现金等价物余额9,502,388,906.0410,082,162,808.8612,059,372,890.8112,120,741,361.41
最新报告期:2024-04-09
研究机构分析师预测每股收益(元)更新日
2023年2024年2025年
浙商证券孙建,郭双喜1.191.501.742024-04-09
中泰证券张楠,祝嘉琦1.161.291.452024-04-08
中金公司俞波,高远1.121.28--2024-04-03
光大证券王明瑞1.411.762.062024-04-01
国联证券夏禹,郑薇1.401.701.902024-03-27
TOP↑